NCT02254057View on ClinicalTrials.gov

Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

October 31, 2002

Conditions
Healthy
Interventions
DRUG

BIBT 986 BS - single rising dose

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02254057 - Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects | Biotech Hunter | Biotech Hunter